[Federal Register Volume 81, Number 6 (Monday, January 11, 2016)]
[Notices]
[Pages 1209-1210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00215]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: IRIX 
Manufacturing, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: IRIX Manufacturing, Inc. applied to be registered as a

[[Page 1210]]

manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants IRIX Manufacturing, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated August 10, 2015, and 
published in the Federal Register on August 18, 2015, 80 FR 50035, IRIX 
Manufacturing, Inc., 309 Delaware Street, Building 1106, Greenville, 
South Carolina 29605 applied to be registered as a manufacturer of 
certain basic classes of controlled substances. No comments or 
objections were submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of IRIX Manufacturing, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances synthetically as Active Pharmaceutical Ingredients (API) for 
clinical trials.

    Dated: January 4, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-00215 Filed 1-8-16; 8:45 am]
 BILLING CODE 4410-09-P